Expression of mu-opioid receptors in human chronic inflamed knee joint synovium tissue
|Updated:2026-03-12
|
Expression of mu-opioid receptors in human chronic inflamed knee joint synovium tissue
Expression of mu-opioid receptors in human chronic inflamed knee joint synovium tissue
解放军医学杂志(英文版)2006年第6期 页码:397-400
Affiliations:
1. Department of Anesthesiology Changzheng Hospital Second Military Medical University
2. ,China
Author bio:
Funds:
Supported by Science and Research Foundation of Shanghai Municipal Health Bureau (200537103)
DOI:
中图分类号:R684
纸质出版:2006
Accepted:
Scan QR Code
Expression of mu-opioid receptors in human chronic inflamed knee joint synovium tissue[J]. 解放军医学杂志(英文版), 2006,(6):397-400.
[1]袁红斌,何星颖,徐海涛,朱秋峰,王亚华,石学银.Expression of mu-opioid receptors in human chronic inflamed knee joint synovium tissue[J].Journal of Medical Colleges of PLA,2006(06):397-400.
Expression of mu-opioid receptors in human chronic inflamed knee joint synovium tissue[J]. 解放军医学杂志(英文版), 2006,(6):397-400.DOI:
[1]袁红斌,何星颖,徐海涛,朱秋峰,王亚华,石学银.Expression of mu-opioid receptors in human chronic inflamed knee joint synovium tissue[J].Journal of Medical Colleges of PLA,2006(06):397-400.DOI:
Expression of mu-opioid receptors in human chronic inflamed knee joint synovium tissue
摘要
Abstract
<正>Objective: To examine the changes of mu-opioid receptors (MORs) expression in human chronic inflamed knee joint synovium tissue. Methods:Knee joint synovium tissues were taken from 21 patients with chronic arthritis (inflamed group) and 6 fresh bodies with normal knee joints (control group). And the expression of MORs was detected by using immunohistochemistry. flow cytometry(FCM) and reverse-transcription polymerase chain reaction (RT-PCR). Results: The expression of MORs in the inflamed group was significantly higher than that in the normal group by using the 3 techniques(P<0. 05). Conclusion: Chronic inflammation enhances the up-regulation of MORs in human knee joint synovium tissue.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.